Evidence map›Paper›PMID 41313221›Full record

ArticleEuropean journal of translational myology2026

Parry-Romberg syndrome associated with ataxia: description of a patient improved after neurorehabilitation.

Gianluca Regazzo, Francesco Piccione, Marco Marenghi, Paola Contessa, Stefano Masiero

Abstract read
In one paragraph

Article in European journal of translational myology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gianluca RegazzoDepartment of Neuroscience, Rehabilitation Unit, University of Padua, Padua, Italy; Physical Medi-cine and Rehabilitation School, Department of Neuroscience, University of Padua.
Francesco PiccioneDepartment of Neuroscience, Rehabilitation Unit, University of Padua, Padua.
Marco MarenghiDepartment of Neuroscience, Rehabilitation Unit, University of Padua, Padua, Italy; Physical Medi-cine and Rehabilitation School, Department of Neuroscience, University of Padua.
Paola ContessaDepartment of Neuroscience, Rehabilitation Unit, University of Padua, Padua.
Stefano MasieroDepartment of Neuroscience, Rehabilitation Unit, University of Padua, Padua, Italy; Physical Medi-cine and Rehabilitation School, Department of Neuroscience, University of Padua.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parry-Romberg Syndrome (PRS) is a rare condition that can affect the musculoskeletal system, resulting in progressive motor disabilities. The existing literature provides limited evidence regarding physical therapy interventions for PRS. We present a case of a 69-year-old woman diagnosed with PRS with associated ataxia treated with a neurorehabilitative program aimed at improving motor function and balance. We administered various functional scales (SPPB, Tampa Scale of Kinesiophobia, Berg Balance Scale, and Tinetti Scale). Additionally, a standardized gait analysis was conducted in our Gait and Motion Laboratory. Following neurorehabilitative therapy, the patient exhibited significant positive changes in various motor outcomes, as demonstrated by improvements in scores on standardized tests (SPBB, Berg, TSK and Tinetti scales when compared pre- and post-treatment), as well as enhancements in biomechanical parameters and quality of life (FIM, SF-12). This case report suggests that neurorehabilitative therapy can be beneficial in improving motor function and balance in PRS patient, as well as other rare condition associated with disabilities.

Indexed as

ataxiagait analysisneurorehabilitationParry-Romberg Syndrome

Identifiers

PMID41313221
PMCPMC13088070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.